Expression and purification of BamA, OmpX and tOmpA

PW Paul White
SH Samuel F. Haysom
MI Matthew G. Iadanza
AH Anna J. Higgins
JM Jonathan M. Machin
JW James M. Whitehouse
JH Jim E. Horne
BS Bob Schiffrin
CC Charlotte Carpenter-Platt
AC Antonio N. Calabrese
KS Kelly M. Storek
SR Steven T. Rutherford
DB David J. Brockwell
NR Neil A. Ranson
SR Sheena E. Radford
request Request a Protocol
ask Ask a question
Favorite

BamA, OmpX and tOmpA were expressed as inclusion bodies in E. coli BL21(DE3) cells, using a procedure modified from McMorran et al. 50. Briefly, inclusion bodies were solubilised in 25 mM Tris–HCl pH 8.0, 6 M guanidine–HCl and were centrifuged (20,000×g, 20 min, 4 °C) to remove remaining insoluble material. The solubilised inclusion bodies were purified by SEC using a Superdex 75 HiLoad 26/60 column (GE Healthcare) for tOmpA and OmpX, and Sephacryl 200 26/60 column for BamA, equilibrated in 25 mM Tris–HCl pH 8.0, 6 M guanidine–HCl. For folding experiments, OmpX and tOmpA were buffer exchanged into Tris-buffered saline (TBS, 20 mM Tris–HCl, 150 mM NaCl) pH 8.0, 8 M urea using Zeba™ Spin Desalting Columns, 7k MWCO, 0.5 mL (Thermo Scientific). BamA was refolded in LDAO detergent prior to reconstitution into proteoliposomes, as described previously62 (see below).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A